Core Viewpoint - Revival Gold Inc. has announced an upsized strategic placement with EMR Capital Management Limited, raising gross proceeds of US$11.3 million (C$15.4 million) through the sale of 32,069,531 common shares at a price of C$0.48 per share [1][2][3]. Group 1: Strategic Placement Details - EMR's pro-forma interest in Revival Gold is expected to be approximately 12.00% upon closing, assuming full subscription of the Concurrent Offering [2]. - The EMR Strategic Placement includes customary anti-dilution rights and the right to nominate a director to the Board of Directors [2]. - The total raise has been upsized to accommodate significant demand, allowing the company to advance its projects and plans [3]. Group 2: Concurrent Offering - The company has also upsized its non-brokered private placement to up to C$11.6 million, issuing up to 24,180,469 common shares at the same price of C$0.48 per share [4]. - The Common Shares under the Concurrent Offering will be offered to purchasers in Canada (except Quebec) and may also be issued to purchasers outside Canada, including the United States, under applicable regulatory requirements [5]. Group 3: Use of Proceeds - The net proceeds from both the EMR Strategic Placement and the Concurrent Offering will be utilized for the ongoing exploration and development of the Mercur and Beartrack-Arnett projects, as well as for general working capital and corporate purposes [6]. Group 4: Closing Conditions - The EMR Strategic Placement and the Concurrent Offering are subject to customary closing conditions, including necessary regulatory approvals, with expected closing around July 29, 2025 [8].

Core Viewpoint - Revival Gold Inc. has announced a strategic placement with EMR Capital Management Limited, which will result in a significant cash injection of US$10 million to support the company's gold production initiatives [1][3]. Group 1: EMR Strategic Placement - EMR will purchase 28,506,250 common shares at a price of C$0.48 per share, totaling gross proceeds of US$10 million (C$13.68 million) [1]. - EMR's pro-forma interest in Revival Gold is expected to be approximately 10.86% upon closing, assuming full subscription of the Concurrent Offering [2]. - EMR will receive customary anti-dilution rights and the right to nominate a director to the Board of Directors of Revival Gold [2]. Group 2: Concurrent Offering - Revival Gold plans to complete a non-brokered private placement of up to C$10.32 million by issuing up to 21,493,750 common shares at the same price of C$0.48 per share [4]. - The proceeds from both the EMR Strategic Placement and the Concurrent Offering will be used for the exploration and development of the Mercur and Beartrack-Arnett projects, as well as for general working capital [6]. Group 3: Regulatory and Closing Conditions - The offerings are subject to customary closing conditions, including necessary regulatory approvals, with expected closing around July 29, 2025 [8]. - Common shares issued under the Concurrent Offering will be offered to purchasers in Canada and may also be issued to purchasers outside Canada, including the United States, under applicable regulatory requirements [5]. Group 4: Company Overview - Revival Gold is one of the largest pure gold mine developers in the United States, focusing on the Mercur Gold Project in Utah and the Beartrack-Arnett Gold Project in Idaho [13].